P3.03-05 Comparative Transcriptomic Analysis of Lung-iPSC, NSCLC, and SCLC: Potential Implications for iPSC Modeling of Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1682
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.03-10 Transcriptomic Differences Between Early and Late Stage Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Characterization of Human iPSC-derived Astrocytes With Potential for Disease Modeling and Drug Discovery

2019English

P1.11-05 Metabolomic Profiling for Second Primary Lung Cancer Among Lung Cancer Survivors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

GP13 Differential miRNA Expression in CF and Gene Corrected iPSC-derived Lung Organoids

2019English

P3.03-17 Roles of Α7nAchR Signaling in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

P3.03-15 Lung Cancer Regulation of Glucose Metabolic Stress Response

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Validation of an Algorithm Able to Differentiate Small-Cell Lung Cancer (SCLC) From Non-Small-Cell Lung Cancer (NSCLC) Patients by Means of a Tumour Marker Panel: Analysis of the Errors

British Journal of Cancer
Cancer ResearchOncology
1997English

P2.15-05 Prescribing Patterns of Physicians and Financial Implications for Lung Cancer Treatment at the End of Life

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy